info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_SECONDARY_NAS_EXALLC for full statistics.

Secondary malignant neoplasm of other and unspecified sites

C3_SECONDARY_NAS

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cause of death: ICD-10 C79
Cause of death: ICD-8 198
Cancer registry: Topography ICD-O-3 C79
Cancer registry: Morphology ICD-O-3 ANY
Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

318

diagram downward connector

Check minimum number of events None

318

diagram downward connector

Include endpoints None

318

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

307

diagram downward connector
C3_SECONDARY_NAS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF9

Similar endpoints

List of similar endpoints to Secondary malignant neoplasm of other and unspecified sites based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 307 120 187
Unadjusted prevalence (%) 0.07 0.05 0.10
Mean age at first event (years) 71.07 66.92 73.74

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: C3_SECONDARY_NAS – Secondary malignant neoplasm of other and unspecified sites
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Secondary malignant neoplasm of other and unspecified sites

Endpoint not on priority list, no data to show.